A Primer for Primary-Care – Guide to ADPKD is an accredited educational program focusing on the management of ADPKD for primary care practitioners in Canada. Join us for this uniquely interactive program that includes a patient case to learn more on the epidemiology and genetics of ADPKD. Discuss diagnostic criteria and complications associated with ADPKD and the essential role of primary-care practitioners in managing them. This program also includes key characteristics and data on the ADPKD-specific treatment, tolvaptan. Lastly, participate in discussions and polling questions to reflect on the knowledge gained and possible changes to practice.
BACK
November 25, 2021
7:00 pm - 
8:00 pm - 
5:00 pm - 
4:00 pm - 
8:30 pm EST
9:30 pm AST
6:30 pm MST
5:30 pm PST
LEARNING OBJECTIVES
After completing this learning activity, participants will be better able to:
  • Identify people at risk for ADPKD
  • Apply diagnostic criteria to differentiate between ADPKD and other causes of kidney cysts
  • Refer patients with ADPKD to nephrology early in the disease course
  • Monitor for and treat the most common renal and extrarenal complications of ADPKD
  • Discuss the rationale for ADPKD-specific treatment with tolvaptan

Presented by:

Pierre Antoine Brown
MD, FRCPC, M.Sc


REGISTER FOR
THIS WEBINAR







The following is a CFPC accredited Group Learning program that has been approved for up to 1.5 Mainpro+ credits. Please note that you can claim your Mainpro+ credits in a different chapter in your region using the session’s ID.

This learning program is brought to you by the CPD Network Association, a not-for-profit physician organization, with an educational grant and in-kind support from Otsuka Canada Pharmaceutical Inc. (OCPI).